C122H115Cl8N37O9 — CID 159534439
3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]benzamide;3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]-N,N-dimethylbenzamide;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-[(4-methoxyphenyl)methyl]pyrazol-3-yl]ethyl]-3-[[5-chloro-2-(tetrazol-1-yl)phenyl]methyl]urea;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[3-(morpholine-4-carbonyl)phenyl]ethyl]-3-[[5-chloro-2-(tetrazol-1-yl)phenyl]methyl]urea (PubChem CID 159534439) has the molecular formula C122H115Cl8N37O9 and a molecular weight of 2527.14 g/mol. Its IUPAC name is 3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]benzamide;3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]-N,N-dimethylbenzamide;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-[(4-methoxyphenyl)methyl]pyrazol-3-yl]ethyl]-3-[[5-chloro-2-(tetrazol-1-yl)phenyl]methyl]urea;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[3-(morpholine-4-carbonyl)phenyl]ethyl]-3-[[5-chloro-2-(tetrazol-1-yl)phenyl]methyl]urea.
| Compound Name | 3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]benzamide;3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]-N,N-dimethylbenzamide;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-[(4-methoxyphenyl)methyl]pyrazol-3-yl]ethyl]-3-[[5-chloro-2-(tetrazol-1-yl)phenyl]methyl]urea;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[3-(morpholine-4-carbonyl)phenyl]ethyl]-3-[[5-chloro-2-(tetrazol-1-yl)phenyl]methyl]urea |
|---|---|
| PubChem CID | 159534439 |
| Molecular Formula | C122H115Cl8N37O9 |
| Molecular Weight | 2527.14 g/mol |
| Exact Mass | 2521.72 |
| IUPAC Name | 3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]benzamide;3-[(2S)-2-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoylamino]ethyl]-N,N-dimethylbenzamide;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[1-[(4-methoxyphenyl)methyl]pyrazol-3-yl]ethyl]-3-[[5-chloro-2-(tetrazol-1-yl)phenyl]methyl]urea;1-[(1S)-1-[5-chloro-4-(4-methylphenyl)-1H-imidazol-2-yl]-2-[3-(morpholine-4-carbonyl)phenyl]ethyl]-3-[[5-chloro-2-(tetrazol-1-yl)phenyl]methyl]urea |
| SMILES | COc1ccc(Cn2ccc(C[C@H](NC(=O)NCc3cc(Cl)ccc3-n3cnnn3)c3nc(-c4ccc(C)cc4)c(Cl)[nH]3)n2)cc1.Cc1ccc(-c2nc([C@H](Cc3cccc(C(=O)N(C)C)c3)NC(=O)NCc3cc(Cl)ccc3-n3cnnn3)[nH]c2Cl)cc1.Cc1ccc(-c2nc([C@H](Cc3cccc(C(=O)N4CCOCC4)c3)NC(=O)NCc3cc(Cl)ccc3-n3cnnn3)[nH]c2Cl)cc1.Cc1ccc(-c2nc([C@H](Cc3cccc(C(N)=O)c3)NC(=O)NCc3cc(Cl)ccc3-n3cnnn3)[nH]c2Cl)cc1 |
| InChI | InChI=1S/C32H30Cl2N10O2.C32H31Cl2N9O3.C30H29Cl2N9O2.C28H25Cl2N9O2/c1-20-3-7-22(8-4-20)29-30(34)39-31(38-29)27(16-25-13-14-43(40-25)18-21-5-10-26(46-2)11-6-21)37-32(45)35-17-23-15-24(33)9-12-28(23)44-19-36-41-42-44;1-20-5-7-22(8-6-20)28-29(34)39-30(38-28)26(16-21-3-2-4-23(15-21)31(44)42-11-13-46-14-12-42)37-32(45)35-18-24-17-25(33)9-10-27(24)43-19-36-40-41-43;1-18-7-9-20(10-8-18)26-27(32)37-28(36-26)24(14-19-5-4-6-21(13-19)29(42)40(2)3)35-30(43)33-16-22-15-23(31)11-12-25(22)41-17-34-38-39-41;1-16-5-7-18(8-6-16)24-25(30)36-27(35-24)22(12-17-3-2-4-19(11-17)26(31)40)34-28(41)32-14-20-13-21(29)9-10-23(20)39-15-33-37-38-39/h3-15,19,27H,16-18H2,1-2H3,(H,38,39)(H2,35,37,45);2-10,15,17,19,26H,11-14,16,18H2,1H3,(H,38,39)(H2,35,37,45);4-13,15,17,24H,14,16H2,1-3H3,(H,36,37)(H2,33,35,43);2-11,13,15,22H,12,14H2,1H3,(H2,31,40)(H,35,36)(H2,32,34,41)/t27-;26-;24-;22-/m0000/s1 |
| InChIKey | MDKJCTLHMKBJCR-DRXYLINESA-N |
| XLogP | 20.33 |
| TPSA | 573.63 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 176 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2527.14 |
| LogP ≤ 5 | 20.33 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 31 |